Skip to main content
. 2016 Jan 24;7(8):9084–9101. doi: 10.18632/oncotarget.7000

Table 4. Multivariate Analysis (Cox regression) on the Overall Survival and Disease-free Survival.

Variables Overall Survival Disease-free Survival
95% CI 95% CI
RR Lower Upper P RR Lower Upper P
Age 2.228 1.598 3.106 <0.001* 1.344 1.016 1.779 0.038*
WBC§ 2.192 1.539 3.123 <0.001* 1.731 1.285 2.331 <0.001*
KaryotypeΨ 2.227 1.230 4.032 0.008* 1.792 1.087 2.955 0.022*
NPM1/FLT3-ITDζ 0.343 0.171 0.686 0.002* 0.304 0.163 0.567 <0.001*
CEBPA 0.462 0.238 0.896 0.022* 0.630 0.392 1.014 0.057
RUNX1 1.942 1.129 3.339 0.016* 1.788 1.138 2.809 0.012*
WT1 2.560 1.508 4.346 <0.001* 2.469 1.614 3.778 <0.001*
ASXL1 1.126 0.622 2.039 0.695 0.978 0.562 1.704 0.938
IDH2** 0.539 0.284 1.020 0.058 0.840 0.530 1.333 0.459
DNMT3A 1.919 1.166 3.158 0.010* 2.130 1.400 3.241 <0.001*
TP53 3.613 1.598 8.167 0.002* 2.824 1.372 5.812 0.005*
SF 2.243 1.380 3.647 0.001* 2.136 1.376 3.314 0.001*

Abbreviation: RR, relative risk; CI, confidence interval, SF, splicing factor.

*

Statistically significant (P < 0.05)

Age > 50 relative to Age ≤50 (the reference)

§

WBC greater than 50,000/μL vs. 50,000/μL or less

ζ

NPM1mut/FLT3-ITDneg vs. other subtypes

CEBPAdouble-mutation vs. others

Ψ

unfavorable cytogenetics vs. others

**

IDH2 mutations included R140 and R172 mutations